These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 22524834)

  • 1. Early efficacy of taxotere and cisplatin chemo-radiotherapy for advanced cervical cancer.
    Ke QH; Zhou SQ; Du W; Lei Y; Huang M; Luo F; Yang JY
    Asian Pac J Cancer Prev; 2012; 13(2):617-9. PubMed ID: 22524834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized controlled study of single-agent cisplatin and radiotherapy versus docetaxel/cisplatin and radiotherapy in high-risk early-stage cervical cancer after radical surgery.
    Pu J; Qin SS; Ding JX; Zhang Y; Zhu WG; Yu CH; Li T; Tao GZ; Ji FZ; Zhou XL; Han JH; Ji YL; Sun JX
    J Cancer Res Clin Oncol; 2013 Apr; 139(4):703-8. PubMed ID: 23328996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Randomized Controlled Trial Comparing Clinical Outcomes and Toxicity of Lobaplatin- Versus Cisplatin-Based Concurrent Chemotherapy Plus Radiotherapy and High-Dose-Rate Brachytherapy for FIGO Stage II and III Cervical Cancer.
    Wang JQ; Wang T; Shi F; Yang YY; Su J; Chai YL; Liu Z
    Asian Pac J Cancer Prev; 2015; 16(14):5957-61. PubMed ID: 26320479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Induction chemotherapy with docetaxel plus cisplatin (TP regimen) followed by concurrent chemoradiotherapy with TP regimen versus cisplatin in treating locally advanced nasopharyngeal carcinoma].
    Xie FY; Zou GR; Hu WH; Qi SN; Peng M; Li JS
    Ai Zheng; 2009 Mar; 28(3):279-85. PubMed ID: 19619443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Treatment of Pelvic Locoregional Recurrence of Cervical Cancer After Radical Surgery With Intensity-Modulated Radiation Therapy Compared With Conventional Radiotherapy: A Retrospective Study.
    Yin YJ; Li HQ; Sheng XG; Du XL; Wang C; Lu CH; Pan CX
    Int J Gynecol Cancer; 2015 Jul; 25(6):1058-65. PubMed ID: 25647254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent Chemoradiation with Weekly Paclitaxel and Cisplatin for Locally Advanced Cervical Cancer.
    Kalaghchi B; Abdi R; Amouzegar-Hashemi F; Esmati E; Alikhasi A
    Asian Pac J Cancer Prev; 2016; 17(S3):287-91. PubMed ID: 27165240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Treatment Time on Chemoradiotherapy in Locally Advanced Cervical Carcinoma.
    Pathy S; Kumar L; Pandey RM; Upadhyay A; Roy S; Dadhwal V; Madan R; Chander S
    Asian Pac J Cancer Prev; 2015; 16(12):5075-9. PubMed ID: 26163644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of the initial efficacy of nedaplatin combined with megestrol in concurrent chemoradiotherapy for advanced cervical cancer].
    Ke QH; Zhou SQ; Su XY; Liu Z; Zhang WT; Yang JY
    Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):629-31. PubMed ID: 22325227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of concurrent chemoradiotherapy plus adjuvant chemotherapy on advanced cervical cancer.
    Wang S; Zhang DS; Pan T; Liu S; Wang MK
    Chin J Cancer; 2010 Nov; 29(11):959-63. PubMed ID: 20979696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of uterine arterial chemoembolization and uterine arterial infusion chemotherapy for advanced cervical cancer before radical radiotherapy: a long-term follow-up study.
    Tian ZZ; Li S; Wang Y; Yue YJ; Zhu XH; Zhao R; Zhang CL; Wei SH
    Arch Gynecol Obstet; 2014 Jul; 290(1):155-62. PubMed ID: 24573504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A randomized controlled trial of two chemotherapy regimens (paclitaxel liposome combined with platinum and paclitaxel combined with platinum) in concurrent chemoradiotherapy for cervical carcinoma].
    Zeng SY; Li L; Zhong ML; Jiang W; Wu YY; Liu Y
    Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):517-9. PubMed ID: 22093629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of induction chemotherapy with vinorelbine plus cisplatin (NP) or docetaxel plus cisplatin (TP) combined with concurrent chemoradiotherapy for patients with locally advanced nasopharyngeal carcinoma].
    Han SH; Yu L; Zhang Z; Zhang PJ; Song HP; Guo CY
    Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):623-6. PubMed ID: 24314223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility and acute toxicity of Concurrent Chemoradiotherapy (CCRT) with high-dose rate intracavitary brachytherapy (HDR-ICBT) and 40-mg/m2 weekly cisplatin for Japanese patients with cervical cancer: results of a Multi-Institutional Phase 2 Study (JGOG1066).
    Toita T; Kitagawa R; Hamano T; Umayahara K; Hirashima Y; Aoki Y; Oguchi M; Mikami M; Takizawa K;
    Int J Gynecol Cancer; 2012 Oct; 22(8):1420-6. PubMed ID: 22932262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Taxan induction chemotherapy and concomitant chemoradiotherapy with cisplatin in patients with locally advanced head and neck cancer--early results].
    Chilimoniuk M; Olszewska E; Maksimowicz T
    Pol Merkur Lekarski; 2010 Dec; 29(174):357-60. PubMed ID: 21298984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Concurrent chemoradiotherapy versus radiotherapy in advanced cervical carcinoma].
    Zeng SY; Li LY; Shu KY; Pan M; Li HP; Luo B
    Ai Zheng; 2008 Sep; 27(9):942-6. PubMed ID: 18799032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome and toxicity of radical radiotherapy or concurrent Chemoradiotherapy for elderly cervical cancer women.
    Wang W; Hou X; Yan J; Shen J; Lian X; Sun S; Liu Z; Meng Q; Wang D; Zhao M; Qiu J; Hu K; Zhang F
    BMC Cancer; 2017 Aug; 17(1):510. PubMed ID: 28764676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison between docetaxel plus cisplatin and cisplatin plus fluorouracil in the neoadjuvant chemoradiotherapy for local advanced esophageal squamous cell carcinoma].
    Wu S; Chen MY; Luo JC; Wei L; Chen Z
    Zhonghua Zhong Liu Za Zhi; 2012 Nov; 34(11):873-6. PubMed ID: 23291141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent chemoradiotherapy incorporating high-dose rate brachytherapy for locally advanced cervical carcinoma: survival outcomes, patterns of failure, and prognostic factors.
    Teh J; Yap SP; Tham I; Sethi VK; Chua EJ; Yeo R; Ho TH; Tay EH; Chia YN; Soh LT; Khoo-Tan HS
    Int J Gynecol Cancer; 2010 Apr; 20(3):428-33. PubMed ID: 20375809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of postoperative simple chemotherapy and concurrent chemoradiotherapy in FIGO stage IB2-IIB cervical cancer].
    Ma K; Yang YH; Yang X; Feng ZY; Liu TY; Wen HW; Liao QP
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Dec; 45(6):910-5. PubMed ID: 24343073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of serum VEGF levels on therapeutic outcome and diagnosis/prognostic value in patients with cervical cancer.
    Du K; Gong HY; Gong ZM
    Asian Pac J Cancer Prev; 2014; 15(20):8793-6. PubMed ID: 25374209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.